Ajanta Pharma Share Price – Keep Eye on ₹1018 level Below No Buying @all – Sell 1Laks, 2 Laks Lots – Aur So Jaaooooooooo – Hint Call By Market Guru Neal Bhai

Ajanta Pharma Share Price – Keep Eye on ₹1018 level Below No Buying @all – Sell 1Laks, 2 Laks Lots – Aur So Jaaooooooooo – Hint Call By Market Guru Neal Bhai

“No Magic, No Miracle, Just Power of Level”

Neal Bhai Reports (NBR) By CFA’s  and MFA’s Technical Team

Mobile No. 9582247600 & 9899900589

Read more →

Cipla Rises On U.S. FDA Nod For Immunodeficiency Drug

Neal Bhai Reports (NBR) — Cipla Rises On U.S. FDA Nod For Immunodeficiency Drug – Shares of the Mumbai-based drugmaker rose as much as 6.47 percent to Rs 622.75 after U.S. FDA gave its final approval to Efavirenz tablets in strength of 600 mg. Efavirenz Tablets 600 mg is AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb Pharma Company’s Sustiva which is used in treatment of human immunodeficiency virus type 1 infection, Cipla said in an exchange filing.

Read more →

Pokarna Declines After Well Known Investor Sells Stake

Gold Silver Reports (GSR) – Pokarna Declines After Well Known Investor Sells Stake – Shares of the Secunderabad-based company engaged in business of granite quarrying fell as much as 3 percent to Rs 174.50 after well-known investor Ashish Kacholia sold 1.2 percent stake in the company.       

Read more →